biotrics bioimplants AG

biotrics bioimplants AG is a privately held German biomedical company specializing in the clinical regeneration of human bone and soft tissue. biotrics develops, manufactures, and markets innovative and established regenerative matrices based on collagen and magnesium for a wide range of surgical applications.

With collagen and magnesium as its core biomaterials, biotrics provides advanced technologies for tissue regeneration. Its indication-optimized products and technologies are based on many years of academic and industrial research and have been developed in close collaboration with leading clinicians, research institutes, and universities.

All products are manufactured at biotrics’ own production facility in Berlin-Tempelhof in accordance with stringent quality, scientific, and certified regulatory standards (e.g., GMP, DIN EN ISO 13485).

In addition to expanding its international distribution network, biotrics is actively seeking strategic partners for contract development, OEM manufacturing, and private-label solutions. With in-house expertise spanning biomaterial development, product design, manufacturing, quality management, and regulatory compliance, biotrics supports partners from early-stage product concepts through development and industrial-scale manufacturing.

biotrics welcomes collaborations with distributors, medical device companies, and other industry partners seeking innovative collagen- or magnesium-based regenerative solutions and reliable manufacturing capabilities.